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Summary
OBJECTIVES: Optimal surveillance and prevention of
healthcare-associated infections (HAI) are crucial for a
well-functioning health care system. With a view to estab-
lishing a national state-of-the-art programme for surveil-
lance and prevention of HAIs, the Swiss National Center
for Infection Control, Swissnoso, developed a survey to
explore the options for expanding the existing Swiss HAI
surveillance system.
METHODS: An online survey was sent to all Swiss acute
care hospitals. Local infection prevention and control (IPC)
professionals were asked to answer on behalf of their in-
stitutions. The questions covered the structure and organ-
isation of IPC programmes, current preventive measures,
availability and capacity of electronic medical record
(EMR) systems, and ability and willingness to establish
and participate in the proposed new surveillance modules.
An invitation was sent to the 156 acute care hospitals and
hospital networks in June 2020. Responses were collect-
ed up to the end of August 2020.
RESULTS: Ninety-four hospitals and hospital networks out
of 156 (60%) completed the survey. Among 84 hospitals
reporting the number of acute care beds, 61 (73%) were
small (<200 beds), 16 (19%) medium (200–650 beds) and
7 (8%) large hospitals (>650 beds). Twenty-nine differ-
ent EMR systems were used in the participating hospi-
tals. Twenty-two hospitals were using a different EMR sys-
tem in their intensive care unit. There were 17 hospitals
(18%) without an EMR system but which planned to in-
troduce one soon, and eight small hospitals (9%) neither
had an EMR system nor were preparing to introduce one.
Surveillance for central-line associated bloodstream infec-
tion, catheter-associated urinary tract infection and ven-
tilator-associated pneumonia were already established in
26 (28%), 15 (16%) and 15 (16%) hospitals, respectively.
Thirty hospitals (36%) would be willing to participate in
the pilot phase of a new surveillance system. Of these,
15 stated that they wanted to be part of the pilot hospital
network, 6 could provide hospital-wide surveillance de-
nominators (such as catheter-days and patient-days) to
compute incidence rates, and 8 indicated interest in doing
both. Large hospitals interested in participating in the pilot
phase reported more full-time equivalent staff available for
surveillance activities than those who did not declare an
interest.
CONCLUSIONS: Baseline information on hospital IPC
structure and process indicators are essential for the roll-
out of national surveillance programmes and for improving
surveillance activities. Having an EMR system in place
and adequate personnel resources dedicated for surveil-
lance activities are crucial prerequisites for developing and
implementing an effective HAI surveillance system. The
lack of an EMR system and the diversity and capacities of
EMR solutions will be the main challenges for successful
implementation of national HAI surveillance modules.
Introduction
Despite the substantial global efforts to prevent healthcare-
associated infections (HAIs), their burden remains signif-
icant as up to 10% of patients in developing and 7% in
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developed countries acquire at least one HAI during their
hospital stay [1].
The revised Swiss Epidemics Law that entered into force
on 1 January 2016 defines goals and strategies for detect-
ing, monitoring, preventing and controlling communica-
ble diseases, and lays the basis for developing a nation-
al programme on HAIs. A national strategy (the so-called
NOSO Strategy) was developed and approved by the Fed-
eral Council in March 2016 [2]. In accordance with the
NOSO Strategy, a national monitoring system is being de-
signed, and the currently existing monitoring programmes
in Switzerland are being further expanded and coordinated
with each other. A centralised surveillance system allows a
better overview of national epidemiology, organisation of
data, bench-marking and the coordination of national in-
terventions for HAI prevention. The COVID-19 pandem-
ic further emphasised the need for centralised national sur-
veillance systems.
Switzerland has a mandatory national surveillance system
for surgical site infections (SSIs); however, to our knowl-
edge, data on other HAIs such as central line-associated
bloodstream infection, catheter-associated urinary tract in-
fection or ventilator-associated pneumonia are recorded by
only a minority of hospitals. The establishment and op-
eration of a national surveillance system for these HAIs
were assigned to the National Centre for Infection Control,
called Swissnoso (www.swissnoso.ch).
With a view to exploring the feasibility of establishing new
surveillance modules and the willingness to participate in
them, Swissnoso developed an online survey and and sent
it out to all Swiss acute care hospitals to gain insight into
current surveillance and prevention practices.
Materials and methods
This was a comprehensive inventory aiming to elicit hos-
pital practices and tools related to prevention of HAI, such
as intravascular bloodstream infections, catheter-associat-
ed urinary tract infection and ventilator-associated pneu-
monia. Based on the systematic review by Zingg et al.,
hospital IPC structure and process indicators were record-
ed, including information on existing surveillance prac-
tices [3]. Definitions of multimodal strategies were provid-
ed by the European Centre for Disease Prevention (ECDC)
point prevalence survey protocol [4, 5]. Electronic medical
record (EMR) capacities such as indwelling devices linked
with microbiological data, generation of denominators of
HAI surveillance (e.g., all positive blood cultures, number
of devices per 1000 patient-days or catheter-days) and au-
tomated data transfer to a centralised database were also
collected. Finally, hospitals were asked whether they want-
ed to participate in the pilot phase of an extended surveil-
lance system and could then indicate the module of their
choice.
The survey was sent to IPC professionals representing
acute care settings according to the Swissnoso address list.
There were 206 acute care hospitals/sites in Switzerland
at that time. In the case of hospital networks, only the
networks and not the individual hospitals were contacted.
Therefore, the survey was sent to 156 Swiss acute care hos-
pitals/networks. The invitation was sent out in late June
2020; all answers were retrieved by the end of August
2020.
No institutional review board approval was deemed neces-
sary, given the quality improvement character of the sur-
vey. Only anonymous patient and ward data were collected
and analysed.
Data analysis was conducted with STATA version 15 (Stat-
aCorp LLC, USA). Significance of differences between
full-time equivalent (FTE) means in different hospital cate-
gories was tested through an independent samples two way
t-test.
Results
Ninety-four questionnaires were returned, corresponding
to a 60% response rate of all registered Swiss acute care
hospitals/networks. Of these, 66 (70%) were from hospi-
tals/networks from the German-speaking, 25 (27%) from
the French-speaking and 3 (3%) from the Italian-speaking
part of the country. Eighty-four hospitals reported the num-
ber of acute-care beds; response rates by hospital size are
presented in table 1.
Use of EMR
Asked whether they use an EMR, 69 (73%) hospitals an-
swered that they already had an EMR, whereas 17 (18%)
did not but had planned to introduce one in due time. Only
eight (i.e. all small hospitals) neither had an EMR nor
planned to use one soon. Table 2 summarises the availabil-
ity of EMR systems by hospital size and table S1 in the ap-
pendix shows equivalent data by language region.
There are 29 different EMR systems in use around Switzer-
land; of these, the most frequently used are Phoenix®, Ines
KIS®, Kisim®, Soarian (Cerner)® and ClevEHR®. Most
hospitals performed device and drug prescription and vital
Table 1: Response rate to the Swissnoso surveillance inventory by hospital size.
Hospital size Response rate by hospital category, n/N (%) Distribution of participating hospitals, n/N (%)
Small (<200 beds) 61/122 (50%) 61/84 (73%)
Medium (200–650 beds) 16/24 (67%) 16/84 (19%)
Large (>650 beds) 7/9 (78%) 7/84 (8%)
Table 2: Electronic medical record (EMR) availability by hospital size.
Hospital size EMR availability, n/N (%)
Yes (%) No (%) Soon (%)
Small (<200 beds) 44/61 (72%) 6/61 (10%) 11/61 (18%)
Medium (200–650 beds) 14/16 (88%) 0 2/16 (12%)
Large (>650 beds) 6/7 (86%) 0 1/7 (14%)
Total 64/84 (76%) 6/84 (7%) 14/84 (17%)
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sign reporting through their EMR, at least at a ward lev-
el. Prescribing ability at an intensive care unit (ICU) level
was less frequent. Extraction of data that serve as denom-
inators, such as device-days, and automated data transfer
into a warehouse/database for further processing were al-
so uncommon functions among the EMR systems in use.
EMR capacities of participating hospitals are summarised
in the appendix (table S2).
The association between FTEs dedicated to IPC surveil-
lance and EMR status by hospital size is shown in figure 1.
There were no statistically significant differences between
dedicated FTEs for surveillance among hospitals accord-
ing to their EMR status.
Multifaceted IPC strategies
Guidelines were most frequently used for antimicrobial use
and surgical site infection prevention at a ward level, and
antimicrobial use and central-line associated bloodstream
infection prevention in the ICU. Most hospitals (65%) re-
ported performing the surgical site infection surveillance
of Swissnoso. Checklists and audits were less common in
both wards and ICUs. Multifaceted prevention and surveil-
lance activities are summarised in the appendix (table S3).
Surveillance activities
Surveillance systems on central line-associated blood-
stream infection , catheter-associated urinary tract infec-
tion and ventilator-associated pneumonia were already es-
tablished in 26 (28%), 15 (16%) and 15 (16%) hospitals,
respectively. Thirty hospitals (36%) were willing to par-
ticipate in the pilot phase of the new national surveillance
system. Among them, 15 wanted to be part of the pilot
hospital network, 6 to provide hospital-wide surveillance
denominators (such as catheter-days and patient-days) for
incidence-rate estimation, and 8 intended to do both. Will-
ingness to participate as a pilot hospital and mean FTEs
dedicated to surveillance by hospital size are shown in fig-
ure 2; willingness to participate by language region is pro-
vided in the appendix (table S4). Large hospitals interested
in being part of the pilot phase tended to have higher FTEs
available for surveillance than those that did not declare an
interest (p = 0.06).
Figure 1: Fulltime equivalents (FTEs) dedicated to healthcare-as-
sociated infection surveillance by hospital size, stratified by elec-
tronic medical record (EMR) availability.Small-size hospitals: <200
beds, medium-size hospitals: 200–650 beds, large-size hospitals:
>650 beds, soon: no EMR available in the hospital but planned to
get one soon, yes: EMR in use in the hospital, no: no EMR in use
in the hospital
Discussion
This is the first national inventory on IPC structure and
process indicators in acute care hospitals in Switzerland.
It summarises key information on IPC strategies of acute
care hospitals in Switzerland. It also allows interpretation
of feasibility and generalisability of the upcoming national
surveillance strategy for HAI.
Ninety-four hospitals/networks participated in the online
survey, which account for more than half of the registered
acute care hospitals (n = 156). If we consider that the sur-
vey was sent at the end of the first wave of the SARS-
CoV-2 pandemic in Switzerland, the response rate exceed-
ed our expectations.
Unsurprisingly, most Swiss hospitals have an EMR. Elec-
tronic health records seem to cover hospital services and
units quite well, allowing for complex functions and better
documentation and sharing of relevant information on pa-
tient care. ICU electronic systems are comparatively less
prevalent, as not all of the participating hospitals have an
ICU. The diversity of the EMR systems is a significant
challenge in establishing a centralised semi-automated sur-
veillance system in Switzerland. Only approximately 15%
of the hospitals considered their EMR to be capable of al-
lowing data transfer – but respondents may have underes-
timated this capacity of their EMR. Nevertheless, efforts
should be directed to the design and development of secure
interfaces linking the national surveillance system and in-
dividual hospital electronic health records.
There was also substantial variation in the implementation
of hospital-wide multifaceted strategies. Although surgical
site infection surveillance is mandatory in Switzerland as
part of the national quality contract, only 65% of the par-
ticipating hospitals used the surgical site infection surveil-
lance as part of their IPC multimodal strategy on pre-
vention of surgical site infections. Discrepancies may be
linked to potential barriers of perception between institu-
tional surgical site infection surveillance and hospital-wide
implementation, leading to biased responses.
Although participation in the survey was satisfactory in our
opinion, only a small number of hospitals have volunteered
to participate in the pilot phase of the new Swissnoso sur-
veillance system. The discrepancy between hospitals do-
ing surveillance activities but not being interested in par-
Figure 2: Fulltime equivalents (FTEs) dedicated to healthcare-as-
sociated infection surveillance by hospital size, stratified by willing-
ness to participate as a pilot hospital in a national surveillance net-
work
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ticipating in a national surveillance system raises questions
on potential barriers to successful implementation of a na-
tional surveillance strategy. We hypothesise that sufficient
staff and infrastructure (such as availability of an EMR that
could facilitate automated procedures) would have played
a major role in that.
Large hospitals interested in becoming pilot hospitals had
higher FTEs available for surveillance than those that did
not express such interest. This observation suggests that
sufficient staffing is key for development of effective IPC
strategies, including surveillance activities. However,
high-quality data cannot be generated by computerised
systems only. Qualified staff are needed, and the new
“Schwerpunkt Infektprävention” (IPC subspecialty) for
physicians (as of 1 July 2021) as well as “Fachexpertin für
Infektprävention” for nurses and individuals with equiva-
lent education will ensure that Swiss surveillance data con-
tinue to excel in terms of quality, as observed in the hospi-
tal infection surveillance study by the ECDC [6].
Our survey has several limitations; the number of partici-
pating hospitals may not adequately represent the distrib-
ution of Swiss acute care hospitals. Large hospitals were
overrepresented, corresponding to 8% of participating hos-
pitals (they represent 6% of Swiss acute care hospitals).
As the survey was sent during the COVID-19 pandemic,
one explanation might be that large hospitals had more re-
sources for IPC activities. Second, there was no adjust-
ment for the presence of confounding factors. Willingness
to participate as a pilot hospital was not adjusted for poten-
tial confounders, such as doing well financially, nosocomi-
al infection rate, linguistic region, etc., which decreases the
validity of generalisation. Third, following the discovery
of discordant responses on Swissnoso surgical site infec-
tion surveillance participation, it is assumed that respon-
ders might be prone to bias in their answers regarding
multimodal strategies on HAI prevention implemented at
hospital level; one hypothesis is that the ongoing health
crisis might alter the perception of IPC strategies at a hos-
pital level and/or impact the time dedicated by the respon-
ders in the questionnaire completion. Finally, there were
missing data as the inventory permitted missing or skip-
ping questions.
Despite these limitations, this is the first nationwide inven-
tory on IPC indicators, surveillance activities and EMR ca-
pacities in Swiss acute care hospitals with data collection
done via an online questionnaire. These data will serve as
the basis for developing an extended surveillance system
and identifying the hospitals that will build the future hos-
pital surveillance network.
Conclusion
This inventory collected essential baseline information on
hospital IPC structural and process indicators and the hos-
pitals’ surveillance capacities. Computerised health
records and educated staff dedicated to surveillance are
key elements of a successful surveillance system. Hospi-
tals that are interested in and have the necessary infrastruc-
ture for surveillance activities in Switzerland were identi-
fied. These hospitals will be invited in due time to join in
the pilot phase of the surveillance modules.
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Appendix Supplementary tables
Table S1: EMR status by linguistic region.
Linguistic region EMR availability
Not yet but planned Yes No
German 10 52 4
French 6 15 4
Italian 3 2 0
Total 19 69 8
Table S2: EMR capacities by hospital site.
Hospital site Device ordering Drug prescription Vital sign reports Catheter-days extraction Possibility of data trans-
fer
General ward 70 (74%) 74 (79%) 72 (77%) 37 (39%) 14 (15%)
ICU 39 (41%) 36 (38%) 32 (34%) 26 (28%) 9 (10%)
Other* 32 (34%) 34 (36%) 31 (33%) 25 (27%) 16 (17%)
EMR = electronic medical record; ICU = intensive care unit * Operatoring room, emergency department, recovery room, outpatient clinic
Table S3: Multimodal strategies at the ICU or ward level in participating hospitals.
Guidelines Bundle Training Checklist Audit Surveillance Feedback
ICU
VAP 33 (34%) 20 (21%) 20 (21%) 7 (7%) 5 (5%) 13 (14%) 16 (17%)
CLABSI 42 (44%) 19 (20%) 25 (26%) 12 (13%) 7 (7%) 23 (24%) 22 (23%)
CAUTI 40 (42%) 14 (15%) 20 (21%) 10 (10%) 5 (5%) 15 (16%) 16 (17%)
AU 44 (46%) 5 (5%) 18 (19%) 6 (6%) 8 (8%) 19 (20%) 23 (24%)
Ward
PNE 37 (39%) 12 (13%) 15 (16%) 4 (4%) 4 (4%) 8 (8%) 14 (15%)
SSI 53 (55%) 22 (23%) 31 (32%) 17 (18%) 29 (30%) 62 (65%) 47 (49%)
CAUTI 51 (53%) 22 (23%) 29 (30%) 14 (15%) 8 (8%) 14 (15%) 21 (22%)
AU 60 (63%) 8 (8%) 21 (22%) 13 (14%) 10 (10%) 32 (33%) 31 (32%)
AU = antimicrobial use; CAUTI = catheter-associated urinary tract infection; CLABSI = central-line associated bloodstream infection; ICU = intensive care unit; PNE = pneumonia;
SSI = surgical site infection; VAP = ventilator-associated pneumonia
Table S4: Willingness to participate as a pilot hospital by linguistic region.
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